Stoke Therapeutics names Ian Smith as permanent CEO
Go back to Stoke Therapeutics names Ian Smith as permanent CEO| (NASDAQ: STOK) | Delayed: 24.29 -0.08 (0.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.37 | 52 Week High | $ | |||
| Open | $24.13 | 52 Week Low | $ | |||
| Day High | $24.70 | P/E | N/A | |||
| Day Low | $23.95 | EPS | $ | |||
| Volume | 510,490 | |||||



